Inhalational anesthetics US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Inhalational anesthetics. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Inhalational anesthetics US Medical PG Question 1: A 17-year-old male presents with altered mental status. He was recently admitted to the hospital due to a tibial fracture suffered while playing soccer. His nurse states that he is difficult to arouse. His temperature is 98.6 deg F (37 deg C), blood pressure is 130/80 mm Hg, pulse is 60/min, and respirations are 6/min. Exam is notable for pinpoint pupils and significant lethargy. Which of the following describes the mechanism of action of the drug likely causing this patient's altered mental status?
- A. Neuronal hyperpolarization due to sodium influx
- B. Neuronal depolarization due to sodium efflux
- C. Neuronal depolarization due to potassium influx
- D. Neuronal hyperpolarization due to potassium efflux (Correct Answer)
- E. Neuronal hyperpolarization due to chloride influx
Inhalational anesthetics Explanation: ***Neuronal hyperpolarization due to potassium efflux***
- The patient's symptoms of **altered mental status**, **pinpoint pupils**, and **respiratory depression** are classic for **opioid overdose**.
- Opioids act by binding to opioid receptors (mu, delta, kappa), which are **G-protein coupled receptors**. Activation of these receptors leads to **potassium efflux** and **calcium influx inhibition**, causing neuronal hyperpolarization and reduced neuronal excitability.
*Neuronal hyperpolarization due to sodium influx*
- **Sodium influx** typically causes depolarization, not hyperpolarization, making this option inconsistent with the mechanism of inducing neuronal inhibition.
- Hyperpolarization usually involves outward positive current (like potassium efflux) or inward negative current (like chloride influx).
*Neuronal depolarization due to sodium efflux*
- **Sodium efflux** (e.g., via the Na+/K+-ATPase) is crucial for maintaining resting membrane potential, but it does not directly lead to depolarization as described here.
- Depolarization is commonly associated with **sodium influx**, not efflux, causing the membrane potential to become more positive.
*Neuronal depolarization due to potassium influx*
- **Potassium influx** would make the cell less negative inside (depolarization), but this is not the primary mechanism of action for opioids.
- Opioids primarily cause **hyperpolarization** and reduced excitability, making this mechanism incorrect for the observed clinical picture caused by opioid overdose.
*Neuronal hyperpolarization due to chloride influx*
- While **chloride influx** does cause neuronal hyperpolarization (e.g., via GABA-A receptor activation by benzodiazepines), this is the mechanism for **GABAergic drugs**, not opioids.
- Opioids primarily achieve hyperpolarization through **potassium efflux**.
Inhalational anesthetics US Medical PG Question 2: Two hours after undergoing elective cholecystectomy with general anesthesia, a 41-year-old woman is evaluated for decreased mental status. BMI is 36.6 kg/m2. Respirations are 18/min and blood pressure is 126/73 mm Hg. Physical examination shows the endotracheal tube in normal position. She does not respond to sternal rub and gag reflex is absent. Arterial blood gas analysis on room air shows normal PO2 and PCO2 levels. Which of the following anesthetic properties is the most likely cause of these findings?
- A. Low blood solubility
- B. High lipid solubility (Correct Answer)
- C. Low brain-blood partition coefficient
- D. High minimal alveolar concentration
- E. Low cytochrome P450 activity
Inhalational anesthetics Explanation: ***High lipid solubility***
- Anesthetics with **high lipid solubility** accumulate in **adipose tissue** and are slowly released, prolonging their effect, especially in obese patients.
- The patient's **obesity (BMI 36.6 kg/m2)** contributes to a larger reservoir for lipid-soluble drugs, leading to delayed recovery and decreased mental status.
*Low blood solubility*
- **Low blood solubility** implies a rapid equilibrium between the lungs and the blood, leading to a **faster onset and offset** of anesthetic action.
- This property would result in a quicker recovery from anesthesia, which contradicts the patient's prolonged unconsciousness.
*Low brain-blood partition coefficient*
- A **low brain-blood partition coefficient** means the anesthetic does not accumulate significantly in brain tissue relative to blood.
- Agents with this property equilibrate quickly and leave the brain rapidly upon discontinuation, resulting in **fast recovery**, which is inconsistent with the patient's persistent decreased mental status.
*High minimal alveolar concentration*
- **High minimal alveolar concentration (MAC)** means that a higher concentration of the anesthetic gas is required to produce immobility in 50% of patients.
- A high MAC describes the **potency** of an anesthetic and does not directly explain prolonged recovery or decreased mental status in an obese patient, but rather indicates that a larger dose or concentration was needed to achieve anesthesia.
*Low cytochrome P450 activity*
- **Low cytochrome P450 activity** would lead to slower metabolism of drugs that are primarily cleared by this system, potentially prolonging their effects.
- While relevant for some drugs, the primary issue for inhaled anesthetics is their **physical distribution and elimination**, not typically metabolic clearance via Cytochrome P450 enzymes.
Inhalational anesthetics US Medical PG Question 3: A group of researchers is studying various inhaled substances to determine their anesthetic properties. In particular, they are trying to identify an anesthetic with fast onset and quick recovery for use in emergencies. They determine the following data:
Inhalational anesthetic Blood-gas partition coefficient
A 0.15
B 0.92
C 5.42
Which of the following statements is accurate with regard to these inhaled anesthetic substances?
- A. Agent C has the fastest onset of action
- B. Agent A has the fastest onset of action (Correct Answer)
- C. Agent B is the most potent
- D. Agent B has the fastest onset of action
- E. Agent A is the most potent
Inhalational anesthetics Explanation: ***Agent A has the fastest onset of action***
- **Agent A** has the lowest blood-gas partition coefficient (0.15), indicating very low solubility in blood.
- A **low blood-gas partition coefficient** means the anesthetic quickly equilibrates between the lungs and blood, leading to a rapid rise in partial pressure in the brain and thus **fast onset of action** and **quick recovery**.
*Agent C has the fastest onset of action*
- **Agent C** has the highest blood-gas partition coefficient (5.42), indicating high solubility in blood.
- High solubility means the anesthetic takes longer to saturate the blood and reach the brain, resulting in a **slow onset of action** and **slow recovery**.
*Agent B is the most potent*
- **Potency** of an inhaled anesthetic is inversely related to its **Minimum Alveolar Concentration (MAC)**, not directly to its blood-gas partition coefficient.
- While a higher blood-gas coefficient can sometimes correlate with other properties, it does not directly determine potency.
*Agent B has the fastest onset of action*
- **Agent B** has a blood-gas partition coefficient of 0.92, which is higher than Agent A (0.15).
- A higher blood-gas partition coefficient means the anesthetic is more soluble in blood, leading to a **slower onset of action** compared to Agent A.
*Agent A is the most potent*
- **Agent A** has the lowest blood-gas partition coefficient (0.15), which indicates **fast onset** and **rapid recovery**, but not necessarily high potency.
- **Potency** is determined by MAC (Minimum Alveolar Concentration), which is the concentration of anesthetic at 1 atmosphere that produces immobility in 50% of patients challenged with a surgical incision.
Inhalational anesthetics US Medical PG Question 4: In a randomized controlled trial studying a new treatment, the primary endpoint (mortality) occurred in 14.4% of the treatment group and 16.7% of the control group. Which of the following represents the number of patients needed to treat to save one life, based on the primary endpoint?
- A. 1/(0.144 - 0.167)
- B. 1/(0.167 - 0.144) (Correct Answer)
- C. 1/(0.300 - 0.267)
- D. 1/(0.267 - 0.300)
- E. 1/(0.136 - 0.118)
Inhalational anesthetics Explanation: ***1/(0.167 - 0.144)***
- The **Number Needed to Treat (NNT)** is calculated as **1 / Absolute Risk Reduction (ARR)**.
- The **Absolute Risk Reduction (ARR)** is the difference between the event rate in the control group (16.7%) and the event rate in the treatment group (14.4%), which is **0.167 - 0.144**.
*1/(0.144 - 0.167)*
- This calculation represents 1 divided by the **Absolute Risk Increase**, which would be relevant if the treatment increased mortality.
- The **NNT should always be a positive value**, indicating the number of patients to treat to prevent one adverse event.
*1/(0.300 - 0.267)*
- This option uses arbitrary numbers (0.300 and 0.267) that do not correspond to the given **mortality rates** in the problem.
- It does not reflect the correct calculation for **absolute risk reduction** based on the provided data.
*1/(0.267 - 0.300)*
- This option also uses arbitrary numbers not derived from the problem's data, and it would result in a **negative value** for the denominator.
- The difference between event rates of 0.267 and 0.300 is not present in the given information for this study.
*1/(0.136 - 0.118)*
- This calculation uses arbitrary numbers (0.136 and 0.118) that are not consistent with the reported **mortality rates** of 14.4% and 16.7%.
- These values do not represent the **Absolute Risk Reduction** required for calculating NNT in this specific scenario.
Inhalational anesthetics US Medical PG Question 5: A previously healthy 44-year-old man is brought by his coworkers to the emergency department 45 minutes after he became light-headed and collapsed while working in the boiler room of a factory. He did not lose consciousness. His coworkers report that 30 minutes prior to collapsing, he told them he was nauseous and had a headache. The patient appears sweaty and lethargic. He is not oriented to time, place, or person. The patient’s vital signs are as follows: temperature 41°C (105.8°F); heart rate 133/min; respiratory rate 22/min; and blood pressure 90/52 mm Hg. Examination shows equal and reactive pupils. Deep tendon reflexes are 2+ bilaterally. His neck is supple. A 0.9% saline infusion is administered. A urinary catheter is inserted and dark brown urine is collected. The patient’s laboratory test results are as follows:
Laboratory test
Blood
Hemoglobin 15 g/dL
Leukocyte count 18,000/mm3
Platelet count 51,000/mm3
Serum
Na+ 149 mEq/L
K+ 5.0 mEq/L
Cl- 98 mEq/L
Urea nitrogen 42 mg/dL
Glucose 88 mg/dL
Creatinine 1.8 mg/dL
Aspartate aminotransferase (AST, GOT) 210
Alanine aminotransferase (ALT, GPT) 250
Creatine kinase 86,000 U/mL
Which of the following is the most appropriate next step in patient management?
- A. Dantrolene
- B. Acetaminophen therapy
- C. Hemodialysis
- D. Ice water immersion (Correct Answer)
- E. Evaporative cooling
Inhalational anesthetics Explanation: ***Ice water immersion***
- This patient presents with signs and symptoms consistent with **heat stroke**, including high body temperature (41°C), altered mental status, and a history of working in a hot environment (boiler room). **Rapid aggressive cooling** is the most critical immediate intervention to prevent organ damage.
- **Ice water immersion** is the fastest and most effective cooling method for heat stroke, aiming to reduce core body temperature to less than 39°C (102.2°F) within 30 minutes.
*Dantrolene*
- **Dantrolene** is primarily used to treat **malignant hyperthermia** and **neuroleptic malignant syndrome**, conditions caused by abnormal calcium release in muscle cells, not environmental heat exposure.
- While both conditions involve hyperthermia, the underlying pathophysiology and triggers are different from heat stroke.
*Acetaminophen therapy*
- **Acetaminophen** is an antipyretic that works by inhibiting prostaglandin synthesis in the central nervous system, affecting the hypothalamic thermoregulatory center.
- It is **ineffective** for the hyperthermia seen in heat stroke, which is due to a failure of thermoregulation rather than an altered hypothalamic set point, and could potentially worsen liver injury.
*Hemodialysis*
- **Hemodialysis** is indicated for severe **renal failure**, drug overdose, or certain electrolyte imbalances. Although this patient has acute kidney injury (elevated BUN and creatinine, dark urine suggestive of rhabdomyolysis), aggressive cooling is the immediate life-saving intervention for heat stroke.
- While renal support might be necessary later if kidney injury progresses, it is not the most appropriate *initial* next step for hyperthermia and altered mental status.
*Evaporative cooling*
- **Evaporative cooling** (e.g., spraying with lukewarm water and using fans) is a cooling method that can be effective, particularly in environments with low humidity.
- However, for severe heat stroke with a temperature as high as 41°C, **ice water immersion** provides a more rapid and aggressive temperature reduction, which is crucial for improving outcomes.
Inhalational anesthetics US Medical PG Question 6: You are a resident on an anesthesiology service and are considering using nitrous oxide to assist in placing a laryngeal mask airway (LMA) in your patient, who is about to undergo a minor surgical procedure. You remember that nitrous oxide has a very high minimal alveolar concentration (MAC) compared to other anesthetics. This means that nitrous oxide has:
- A. no effect on lipid solubility or potency
- B. decreased lipid solubility and decreased potency (Correct Answer)
- C. decreased lipid solubility and increased potency
- D. increased lipid solubility and increased potency
- E. increased lipid solubility and decreased potency
Inhalational anesthetics Explanation: ***Decreased lipid solubility and decreased potency***
- A **very high MAC** indicates that a large concentration of the anesthetic agent is required to produce immobility in 50% of patients, signifying **low potency**.
- According to the **Meyer-Overton rule**, anesthetic potency is directly correlated with lipid solubility; therefore, low potency implies **decreased lipid solubility**.
*No effect on lipid solubility or potency*
- This statement is incorrect as MAC is a direct measure of potency, and potency is linked to lipid solubility by the **Meyer-Overton rule**.
- A high MAC unequivocally indicates **low potency**, and indirectly, low lipid solubility.
*Decreased lipid solubility and increased potency*
- This is incorrect because **increased potency** would be associated with a **low MAC**.
- Potency and lipid solubility are positively correlated, so decreased lipid solubility would lead to **decreased potency**.
*Increased lipid solubility and increased potency*
- This is incorrect; while **increased lipid solubility** is associated with **increased potency**, increased potency would manifest as a **low MAC**, not a high one.
- The given information states a **very high MAC**, which signifies low potency.
*Increased lipid solubility and decreased potency*
- This statement contradicts the **Meyer-Overton rule**, which establishes a direct relationship between lipid solubility and anesthetic potency.
- Therefore, **increased lipid solubility** should correspond to **increased potency**, not decreased potency.
Inhalational anesthetics US Medical PG Question 7: Which of the following statements regarding the patch shown in the figure is correct?
- A. It is an equal mixture of local anesthetics.
- B. Excessive use can result in methemoglobinemia. (Correct Answer)
- C. 5 ml of a 5 percent mixture contains 50 mg of lignocaine.
- D. It contains lignocaine and ropivacaine in a ratio of 50 percent each.
- E. It should be applied for at least 2 hours before minor procedures.
Inhalational anesthetics Explanation: ***Excessive use can result in methemoglobinemia.***
- The patch shown is likely an **EMLA patch**, which contains **lidocaine** and **prilocaine**. Excessive absorption of prilocaine, especially with large doses or prolonged application, can lead to the formation of **methemoglobinemia**.
- **Prilocaine** is metabolized into **ortho-toluidine**, which is an oxidizing agent that can convert hemoglobin to methemoglobin, reducing the blood's oxygen-carrying capacity.
*It is an equal mixture of local anesthetics.*
- The EMLA patch is a 1:1 mixture of **lidocaine** and **prilocaine**, but the claim that it contains "an equal mixture of local anesthetics" is vague and could imply other compositions not specific to EMLA.
- While it's an equal ratio of two specific local anesthetics, the option's wording is not precise enough to be the *most correct* statement.
*5 ml of a 5 percent mixture contains 50 mg of lignocaine.*
- A 5% solution means 5 grams (5000 mg) per 100 ml. Therefore, 1 ml contains 50 mg of lignocaine.
- Thus, 5 ml of a 5% mixture would contain 250 mg of **lignocaine**, not 50 mg. This statement is mathematically incorrect.
*It contains lignocaine and ropivacaine in a ratio of 50 percent each.*
- **EMLA patches** contain **lidocaine** (lignocaine) and **prilocaine**, not ropivacaine.
- While it is a 50% concentration for each active ingredient, the specific combination of local anesthetics mentioned in this option is incorrect.
*It should be applied for at least 2 hours before minor procedures.*
- For most minor procedures, **EMLA cream** typically requires **30-60 minutes** of application time to achieve adequate topical anesthesia.
- While longer application times (up to 2 hours) may enhance depth of anesthesia for certain procedures, stating that it "should be applied for at least 2 hours" is excessive and not a standard recommendation for minor procedures.
Inhalational anesthetics US Medical PG Question 8: A 32-year-old male patient presents to the emergency department after being found down on a sidewalk. He is able to be aroused but seems confused and confabulates extensively during history taking. Physical exam of the eye reveals nystagmus and the patient is unable to complete finger-to-nose or heel-to-shin testing. Chart review shows that the patient is well known for a long history of alcohol abuse. Which of the following substances should be administered prior to giving IV glucose to this patient?
- A. Vitamin B12
- B. Vitamin B1 (Correct Answer)
- C. Vitamin C
- D. Fomepizole
- E. Folate
Inhalational anesthetics Explanation: ***Vitamin B1***
- This patient presents with signs of **Wernicke-Korsakoff syndrome**, characterized by **nystagmus**, **ataxia** (difficulty with finger-to-nose and heel-to-shin), and **global confusion with confabulation**, in the setting of chronic **alcohol abuse**.
- **Thiamine (Vitamin B1) deficiency** is the underlying cause, and administering IV glucose before thiamine can precipitate or worsen Wernicke encephalopathy by increasing glucose metabolism, which further depletes the already low thiamine stores.
*Vitamin B12*
- While **alcohol abuse** can lead to various nutritional deficiencies, **Vitamin B12 deficiency** is more commonly associated with macrocytic anemia and neurological symptoms like peripheral neuropathy or subacute combined degeneration, not the acute neurological picture described here.
- There is no specific indication to administer B12 prior to glucose in this context.
*Vitamin C*
- **Vitamin C (ascorbic acid) deficiency** causes **scurvy**, presenting with bleeding gums, petechiae, and poor wound healing.
- It is not indicated for the neurological symptoms observed in this patient.
*Fomepizole*
- **Fomepizole** is an antidote used for **methanol or ethylene glycol poisoning** by inhibiting alcohol dehydrogenase.
- There is no information in the patient's presentation to suggest methanol or ethylene glycol toxicity.
*Folate*
- **Folate deficiency** is common in alcoholics and can cause **macrocytic anemia** and contribute to neurological issues like peripheral neuropathy.
- However, it does not address the acute neurological syndrome described (Wernicke-Korsakoff) and its administration is not prioritized before glucose in this specific acute scenario.
Inhalational anesthetics US Medical PG Question 9: A 65-year-old woman with COPD comes to the emergency department with 2-day history of worsening shortness of breath and cough. She often has a mild productive cough, but she noticed that her sputum is more yellow than usual. She has not had any recent fevers, chills, sore throat, or a runny nose. Her only medication is a salmeterol inhaler that she uses twice daily. Her temperature is 36.7°C (98°F), pulse is 104/min, blood pressure is 134/73 mm Hg, respiratory rate is 22/min, and oxygen saturation is 85%. She appears uncomfortable and shows labored breathing. Lung auscultation reveals coarse bibasilar inspiratory crackles. A plain film of the chest shows mild hyperinflation and flattening of the diaphragm but no consolidation. She is started on supplemental oxygen via nasal cannula. Which of the following is the most appropriate initial pharmacotherapy?
- A. Albuterol and montelukast
- B. Albuterol and theophylline
- C. Prednisone and albuterol (Correct Answer)
- D. Roflumilast and prednisone
- E. Prednisone and salmeterol
Inhalational anesthetics Explanation: ***Prednisone and albuterol***
- This patient is experiencing an **acute exacerbation of COPD** (AECOPD) characterized by worsening dyspnea, increased sputum purulence (yellow sputum), and elevated respiratory rate, despite no fever or chills. AECOPD is managed with **systemic corticosteroids** (like prednisone) and **short-acting bronchodilators** (like albuterol).
- Prednisone reduces **airway inflammation**, while albuterol provides rapid **bronchodilation** to relieve bronchospasm and improve airflow.
*Albuterol and montelukast*
- **Montelukast** is a leukotriene receptor antagonist used for chronic asthma management and sometimes for COPD patients with an asthmatic component, but it is not a first-line agent for acute exacerbations.
- While **albuterol** is appropriate, montelukast works too slowly to be the primary acute anti-inflammatory agent needed for an AECOPD.
*Albuterol and theophylline*
- **Theophylline** is a phosphodiesterase inhibitor that can improve lung function but has a narrow therapeutic index and significant side effects, making it a less preferred option, especially in acute settings.
- While **albuterol** is appropriate, theophylline is not generally used as an initial agent for AECOPD given safer and more effective alternatives like corticosteroids.
*Roflumilast and prednisone*
- **Roflumilast** is a phosphodiesterase-4 inhibitor used to reduce exacerbations in patients with severe COPD and chronic bronchitis, but it is a chronic medication and not indicated for acute management.
- While **prednisone** is appropriate, roflumilast is not an acute bronchodilator for immediate relief.
*Prednisone and salmeterol*
- **Salmeterol** is a **long-acting beta-agonist (LABA)**, which is part of the patient's maintenance therapy for COPD. In an acute exacerbation, **short-acting bronchodilators** like albuterol are preferred for rapid relief.
- While **prednisone** is appropriate, continuing salmeterol alone as the bronchodilator in an acute setting is insufficient without a short-acting agent.
Inhalational anesthetics US Medical PG Question 10: A 16-year-old college student presents to the emergency department with a 3-day history of fever, muscle rigidity, and confusion. He was started on a new medication for schizophrenia 2 months ago. There is no history of sore throat, burning micturition, or loose motions. At the hospital, his temperature is 38.6°C (101.5°F); the blood pressure is 108/62 mm Hg; the pulse is 120/min, and the respiratory rate is 16/min. His urine is cola-colored. On physical examination, he is sweating profusely. Treatment is started with antipyretics and intravenous hydration. Which of the following is most likely responsible for this patient's condition?
- A. Diazepam
- B. Phenytoin
- C. Levodopa
- D. Amantadine
- E. Chlorpromazine (Correct Answer)
Inhalational anesthetics Explanation: ***Chlorpromazine***
- The patient's symptoms of **fever**, **muscle rigidity**, and **confusion**, combined with a history of starting an antipsychotic medication (**Chlorpromazine**), are highly indicative of **neuroleptic malignant syndrome (NMS)**.
- **Chlorpromazine** is a typical antipsychotic known to block dopamine receptors, which can lead to NMS. The **cola-colored urine** suggests **rhabdomyolysis**, a common complication of severe muscle rigidity in NMS.
*Diazepam*
- **Diazepam** is a benzodiazepine used to treat anxiety, seizures, and muscle spasms, and does not typically cause NMS.
- Its mechanism of action involves enhancing GABAergic neurotransmission, which is distinct from the dopaminergic blockade associated with NMS.
*Phenytoin*
- **Phenytoin** is an anticonvulsant medication that can cause a variety of side effects, but NMS is not one of them.
- Common side effects include **gingival hyperplasia**, **ataxia**, and **nystagmus**.
*Levodopa*
- **Levodopa** is primarily used to treat Parkinson's disease by increasing dopamine levels in the brain.
- While abrupt withdrawal of **Levodopa** can sometimes precipitate NMS-like symptoms in Parkinson's patients due to inadequate dopamine, starting it does not cause NMS, and it is not typically used for schizophrenia.
*Amantadine*
- **Amantadine** is an antiviral drug also used to treat Parkinson's disease; it is not an antipsychotic.
- It primarily acts as a dopamine agonist and NMDA receptor antagonist, and its use is not associated with causing NMS.
More Inhalational anesthetics US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
